Portfolio Category: Current

NSV News Portfolio News
Ventyx Biosciences
June 6, 2020

Ventyx Biosciences

Developing selective inhibitors of TYK2 for autoimmune diseases.

Read More
Zomagen
January 31, 2020

Zomagen

Developer of small molecules harnessing the therapeutic potential of inflammasome modulation across autoimmune/inflammatory indications.

Read More
Morrow
November 1, 2018

Morrow

Focused on the commercialization of spectacles with digital lens technology.

Read More
DUST Identity
October 18, 2018

DUST Identity

Utilizes diamond crystals to enable secure identification of physical objects.

Read More
Isorg
October 18, 2018

Isorg

Focused on developing an organic photodetector material (OPD) for several commercial applications.

Read More
PlanetIQ
October 18, 2018

PlanetIQ

Focused on generating higher quality atmospheric data through the design of a new satellite-deployed instrument.

Read More
ChromaCure
October 3, 2018

ChromaCure

Focused on the development of a first-in-class oncology therapeutic.

Read More
NorthSea Therapeutics
June 13, 2018

NorthSea Therapeutics

Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.

Read More
Vascular Therapies
October 17, 2017

Vascular Therapies

Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.

Read More
Trellis Bioscience
October 17, 2017

Trellis Bioscience

Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.

Read More
Svelte Medical Systems
October 17, 2017

Svelte Medical Systems

Developer of a radial drug-eluting stent platform to simplify cardiovascular stenting procedures.

Read More
Resolve Therapeutics
October 17, 2017

Resolve Therapeutics

Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.

Read More